Conference Program

3rd Zebrafish for Personalized/Precision Medicine Conference

September 27-29, 2017
Wednesday September 27, 2017
6:00pm – 8:30pm Session I: Advances in Zebrafish Research & Precision Medicine (Opening Lectures, Co-chairs: Xiao-Yan Wen & Ian Scott)
Invited Lectures (30 min/lecture):
(1) Michael Wilson, PhD, The Hospital for Sick Children & University of Toronto
“From mammals to fish and back again: using comparative epigenomics to discover ancient enhancers active in early heart development”
(2) Lila Solnica-Krezel, PhD, Washington University School of Medicine in St. Louis
“Forward and Reverse Genetic Approaches to Scoliosis in Zebrafish”
(3) Peter Liu, MD, University of Ottawa Heart Institute, Canada
“Search for Novel Biomarkers and Biotargets for Precision Medicine in Heart Disease”
(4) Stephen Ekker, PhD, Mayo Clinic, Rochester, USA
“Engineering the Power House of the Cell”
Thursday September 28 2017
9:00am – 12:00pm Session II: Mutagenesis & Disease Modeling (Chair: Stephen Ekker)
A. Invited Lectures: (30 min/lecture)
(1) Erica Davis, Center for Human Disease Modeling, Duke University
“talk title: TBD”
(2) Jeff Essner, PhD, Iowa State University
“Enhanced efficiencies using short regions of homology for precise DNA integration in zebrafish”
B. 6 mini-talks selected from abstracts (15 min/talk)
1:30pm – 4:30pm Session III. Mechanisms of Development, Organ Dysfunction & Disease (Chair: Oliver Bandmann)
A. Invited Lectures: (30 min/lecture)
(1) Catarina Henriques, University of Sheffield, UK
“Telomeres, telomerase and inflammation in zebrafish ageing”
(2) Marie-Andrée Akimenko, University of Ottawa, Canada
“Gene regulation of joint formation in regenerating fins”
B. 6 mini-talks selected from abstracts (15 min/talk)
7:30pm – 10:30pm Session IV. Poster Session (Chair: Ian Scott)
Friday September 29, 2017
9:00am – 12:00pm Session V. Chemical Biology, Pharmacogenomics & Drug Discovery (Chair: Randall Peterson)
A. Invited Lectures: (30 min/lecture)
(1) Pierre Drapeau, University of Montreal, Canada
“Neuroleptics for ALS: small compound screen and small clinical trial”
(2) Edward Burton, MD, DPhil, FRCP, Neurology, University of Pittsburgh, USA
“Unbiased phenotype-based chemical modifier screens in zebrafish models of neurodegenerative movement disorders”
B. 6 mini-talks selected from abstracts (15 min/talk)
1:30pm – 5:00pm Session VI. Translational Research & Drug Development (Closing Lectures, Chair: Xiao-Yan Wen)
Invited Lectures (30 min/lecture):
(1) Ori Rotstein, Director, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital
“Using zebrafish to study mechanisms of inflammation”
(2) Charles Hong, MD, PhD, Pharmacology, Cell and Developmental Biology, Vanderbilt University, USA
“Chemical Genetics of Zebrafish Embryonic Development to Drive Therapeutic Target Discovery in Man”
(3) Clara van Karnebeek, MD, PhD. University of Amsterdam, Netherlands
“Zebrafish modelling for Neurometabollic diseases: Identification of disease mechanisms & treatment targets”
(4) Yibin Feng, Associate Director, School of Chinese Medicine, The University of Hong Kong
“Drug discovery from Chinese medicines: the past, present and future”
(5) Randall Peterson, Dean, College of Pharmacy, University of Utah, USA
“Modeling human CNS disorders in the zebrafish.”
6:30pm – 9:30pm Networking Dinner at Ripley’s Aquarium of Canada